Tagged with P

Cyprus Philippos Patsalis, CEO and founder of NIPD Genetics, tells the story of the creation of Cyprus’s first ever biotech company and all its accomplishments after seven years of existence. He also expands on the necessity to bring more innovation into the Cypriot market.   Can you introduce the history behind…

Cyprus Vakis Frangos, managing director for commercial operations at Delorbis, walks us through the unique history of the company as one of the few local manufacturers in the island as well as his strategic vision to strengthen Delorbis’ brand on the global scene. After four years of existence, Delorbis is already…

Cannabis In a move to capitalize on a global market projected to exceed USD 60 billion by 2024, Cyprus has joined a growing number of European nations in legally permitting the cultivation and provision of medical cannabis.   The Republic will grant two 15-year licenses to private medical cannabis cultivators to…

Algeria Head of the Algerian National Laboratory for the Control of Pharmaceutical Products (LNCPP), an institution he helped found in 1995, Abdelaziz Gharbi describes the LNCPP’s journey, his great motivation to see international collaboration grow, and the role that Algeria can play in a context of regional influence. Last year saw…

Cyprus Mario Sciberras, former general manager for Malta and Gibraltar became general manager for Cyprus, Malta, and Gibraltar in 2016. In this interview, he touches on themes of transparency, GSK’s positioning on the market and its vaccination strategy for the coming years. What have been your main priorities since taking over…

Hong Kong Hye-ja Kim, Pfizer Pharmaceutical Innovative Health (Hong Kong and Macau Lead), shares how Pfizer’s global achievements in 2017 are reflected within the Hong Kong affiliate, the innovative solutions they can offer Hong Kong patients, government and other healthcare stakeholders beyond just a drug, and their continued commitment to extending their…

Regulation Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMMS) for PharmaBoardroom. Today more Canadians are dying in this crisis than at the height of the HIV epidemic. Recognizing that we need to join forces to fight the opioid epidemics in both our nations, Canadians…

Global The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations…

Spain Miguel Angel Calleja, president of the Spanish Society of Hospital Pharmacists (SEFH) introduces the society and the important role it plays in Spain’s healthcare system as the perfect partner for the new government. Furthermore, he highlights the strides they are taking to implement new digital technologies into hospital pharmacies across…

Hong Kong Ian Huen, founder and CEO of Aptorum Group, discusses why Hong Kong was the ideal location to base the company, its exciting development pipeline and his unique management philosophy. Ian, with your asset management background, could you share what inspired you to establish Aptorum Group in 2016? My biotech journey…

UK A spinout from the Roslin Institute that created Dolly the Sheep, Roslin CT is a cell and gene therapy CDMO, with a unique positioning in the field today. Its CEO, Janet Downie, presents the company’s expansion plans and talks about new areas worth pursuing as well as the advantages of…

Hong Kong Colman Chan, CEO of ophthalmology specialist Skyview Optical, outlines recent developments in the Hong Kong eyecare market, Skyview’s evolution as a distributor and how it can foster greater links with Mainland China. What have been some of Skyview Optical’s main achievements and milestones since its establishment? Since creating the company…